AbbVie Sues Alvotech Again Alleging At-Risk Adalimumab Launch

Second Lawsuit For Infringement Under BPCIA

 
• By Dean Rudge
  
Risk
Alvotech And AbbVie have exchanged multiple suits • Source: Shutterstock

More from Biosimilars

More from Products